[1]
Montillo, M. 2009. Ofatumumab: a second generation anti-CD20 monoclonal antibody in chronic lymphocytic leukemia. Hematology Meeting Reports (formerly Haematologica Reports). 3, 3 (Jun. 2009). DOI:https://doi.org/10.4081/hmr.v3i3.583.